ClinVar Miner

Submissions for variant NM_000975.5(RPL11):c.465_475dup (p.Lys159fs)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV002330453 SCV002634265 likely pathogenic Diamond-Blackfan anemia 2017-10-30 criteria provided, single submitter clinical testing The c.465_475dup11 variant, located in coding exon 5 of the RPL11 gene, results from a duplication of CAGAATCAGCA at nucleotide position 465, causing a translational frameshift with a predicted alternate stop codon (p.K159Tfs*39). Several similar frameshift alterations (c.462delA, c.465_466delCA, c.469delA, c.476_477delAA, c.482_484delAGG, c.489_490delGCinsT) have been identified in individuals with Diamond-Blackfan anemia, including three that impact residues downstream of amino acid position 159 (Gazda HT et al. Am. J. Hum. Genet. 2008 Dec;83(6):769-80; Quarello P et al. Haematologica. 2010 Feb;95(2):206-13; Gerrard G et al. Haematologica. 2013 Aug;162(4):530-6; Fores Ballester E et al. Clin Case Rep. 2015 Jun;3(6):392-5). Frameshifts are typically deleterious in nature; however, this frameshift occurs at the 3' terminus of RPL11, is not expected to trigger nonsense-mediated mRNA decay, and results in the elongation of the protein by 17 amino acids. The exact functional impact of these inserted amino acids is unknown at this time. Based on the majority of available evidence to date, this variant is likely to be pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.